Claire Macdougall is an experienced R&D Project Manager currently at Nxera Pharma since April 2023. Previously, Claire held various roles at GSK from October 2020 to March 2023, including Investigator and Senior Scientist within the Oncology Cell Therapy Research Unit. Claire also contributed as a Scientist at Cancer Research UK from January 2019 to October 2020 and completed a PhD at Queen Mary University of London from September 2015 to December 2018. Other experience includes positions as a Research Scientist at GSK, a Research Associate at Novartis, and an Industrial Placement Student at GlaxoSmithKline. Claire holds an MRes in Inflammation: Cellular and Vascular Aspects from Queen Mary University of London and a Bachelor of Science in Human Biology from the University of Birmingham.